Hemorrhage is one of the leading preventable causes of maternal death. The safe use of blood recovery (also referred to as cell salvage) in obstetrics is well established. Blood recovery is the process by which blood is suctioned from the surgical field into a blood recovery device, where the blood is filtered, washed by centrifugation with a saline solution, and then transfused back to the patient. Blood recovery is recommended for elective cesarean sections where there is increased risk of hemorrhage (e.g., placenta previa/accreta, fibroid uterus, history of post-partum hemorrhage, etc.), or significant anemia at time of cesarean section regardless of risk factors for hemorrhage. Blood recovery is also recommended for emergency use in major obstetric hemorrhage from all causes. The safe and effective use of blood recovery requires a dedicated team of trained staff members.
This is a preview of subscription content, log in to check access.
American College of Obstetricians and Gynecologists. ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108(4):1039–47.CrossRefGoogle Scholar
Royal College of Obstetricians and Gynaecologists, editor. Blood transfusion in obstetrics. Green-top guideline no. 47. 2nd ed. London: Royal College of Obstetricians and Gynaecologists; 2015.Google Scholar
The Association of Anaesthetists of Great Britain and Ireland. Safety guideline blood transfusion and the anaesthetist intra-operative cell salvage. London: The Association of Anaesthetists of Great Britain and Ireland; 2009.Google Scholar
Rainaldi MP, Tazzari PL, Scagliarini G, et al. Blood salvage during caesarean section. Br J Anaesth. 1998;80:195–8.CrossRefPubMedGoogle Scholar
Geoghegan J, Middleton L, Moore P, Subseson G, Khan K, Daniels J. Routine cell salvage during elective caesarean section: a pilot randomised trial. Int J Obstet Anesth. 2015;24(1):86–7.CrossRefPubMedGoogle Scholar
DeAndrade D, Waters JH, Triulzi DJ, Alarcon L, Wisniewski MK, Dyga R, Yazer MH. Very low rate of patient-related adverse events associated with the use of intraoperative cell salvage. Transfusion. 2016;56(11):2768–72.CrossRefPubMedGoogle Scholar
Bernstein HH, Rosenblatt MA, Gettes M, Lockwood C. The ability of the Haemonetics 4 cell saver system to remove tissue factor from blood contaminated with amniotic fluid. Anesth Analg. 1997;85:831–3.CrossRefPubMedGoogle Scholar
Waters JH, Biscotti C, Potter P, Phillipson E. Amniotic fluid removal during cell-salvage in the cesarean section patient. Anesthesiology. 2000;92:1531–6.CrossRefPubMedGoogle Scholar